Colinz Laboratories Ltd

Colinz Labs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Colinz Laboratories Ltd

₹ 57.0 -0.87%
20 May - close price
colinz.com BSE: 531210
About

Incorporated in 1986, Colinz Laboratories is in the business of manufacturing and trading in pharmaceutical formulations[1]

Key Points

Business Overview:[1]
http://www.colinz.com/about.html
CLL is a manufacturer and exporter of pharmaceutical formulations for allopathic, ayurvedic, nutraceticals in dosage forms of tablets, capsules, ointments, creams, granules, liquid, orals, injectables, syrups, suppsitories, etc. It also has certain specialized products for Gynaecology, cardiology, gastroenterology, etc.

Website BSE
  • Market Cap ₹ 26.0 Cr.
  • Current Price ₹ 57.0
  • High / Low ₹ 88.7 / 36.0
  • Stock P/E 52.1
  • Book Value ₹ 20.7
  • Dividend Yield 0.00 %
  • ROCE 6.72 %
  • ROE 5.43 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Debtor days have improved from 46.4 to 36.9 days.

Cons

  • Stock is trading at 2.75 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -2.81% over past five years.
  • Company has a low return on equity of 5.73% over last 3 years.
  • Working capital days have increased from 46.9 days to 109 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
1.58 1.84 1.92 1.68 1.72 1.90 1.79 1.71 1.63 1.75 1.86 1.47 1.45
1.47 1.69 1.76 1.55 1.56 1.74 1.67 1.57 1.51 1.59 1.69 1.40 1.35
Operating Profit 0.11 0.15 0.16 0.13 0.16 0.16 0.12 0.14 0.12 0.16 0.17 0.07 0.10
OPM % 6.96% 8.15% 8.33% 7.74% 9.30% 8.42% 6.70% 8.19% 7.36% 9.14% 9.14% 4.76% 6.90%
0.07 0.04 0.05 0.04 0.04 0.04 0.08 0.05 0.11 0.07 0.08 0.08 0.08
Interest 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02
Depreciation 0.05 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03
Profit before tax 0.12 0.15 0.17 0.13 0.16 0.16 0.16 0.15 0.19 0.19 0.21 0.11 0.13
Tax % 41.67% 20.00% 29.41% 23.08% 18.75% 18.75% 25.00% 26.67% 31.58% 26.32% 23.81% 45.45% -23.08%
0.07 0.11 0.12 0.10 0.13 0.12 0.12 0.11 0.14 0.14 0.16 0.05 0.15
EPS in Rs 0.15 0.24 0.26 0.22 0.28 0.26 0.26 0.24 0.31 0.31 0.35 0.11 0.33
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
7.41 7.88 8.10 8.05 7.83 7.59 7.53 6.16 6.97 7.15 7.03 6.53
7.07 7.42 7.65 7.64 7.48 7.24 7.22 5.82 6.38 6.52 6.49 6.04
Operating Profit 0.34 0.46 0.45 0.41 0.35 0.35 0.31 0.34 0.59 0.63 0.54 0.49
OPM % 4.59% 5.84% 5.56% 5.09% 4.47% 4.61% 4.12% 5.52% 8.46% 8.81% 7.68% 7.50%
0.13 0.10 0.10 0.09 0.10 0.12 0.13 0.19 0.17 0.15 0.28 0.30
Interest 0.08 0.12 0.12 0.12 0.08 0.10 0.07 0.09 0.08 0.05 0.04 0.04
Depreciation 0.26 0.30 0.28 0.27 0.22 0.22 0.19 0.19 0.20 0.13 0.13 0.13
Profit before tax 0.13 0.14 0.15 0.11 0.15 0.15 0.18 0.25 0.48 0.60 0.65 0.62
Tax % 46.15% 35.71% 40.00% -27.27% -53.33% 26.67% 27.78% 16.00% 29.17% 23.33% 26.15% 19.35%
0.07 0.10 0.09 0.14 0.23 0.12 0.13 0.21 0.34 0.46 0.49 0.50
EPS in Rs 0.15 0.22 0.20 0.31 0.50 0.26 0.28 0.46 0.74 1.01 1.07 1.09
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -2%
5 Years: -3%
3 Years: -2%
TTM: -7%
Compounded Profit Growth
10 Years: 17%
5 Years: 31%
3 Years: 14%
TTM: 2%
Stock Price CAGR
10 Years: 19%
5 Years: 45%
3 Years: 25%
1 Year: 27%
Return on Equity
10 Years: 4%
5 Years: 5%
3 Years: 6%
Last Year: 5%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 3.54 3.54 3.54 3.54 3.54 3.54 3.54 3.55 3.55 2.52 2.52 2.52
Reserves 2.78 2.62 2.71 2.98 3.21 3.30 3.29 3.75 4.14 5.62 6.43 6.96
1.88 2.53 1.80 0.76 0.42 0.68 0.38 0.99 0.48 0.27 0.57 0.64
1.79 1.97 1.70 2.40 2.42 1.65 1.60 1.81 1.76 1.82 1.84 1.70
Total Liabilities 9.99 10.66 9.75 9.68 9.59 9.17 8.81 10.10 9.93 10.23 11.36 11.82
3.72 3.16 2.88 2.63 2.41 2.21 2.06 2.03 1.86 1.71 1.58 1.70
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.32 0.29 0.29 0.41 0.53 0.50 0.36 0.61 0.67 0.66 1.02 1.04
5.95 7.21 6.58 6.64 6.65 6.46 6.39 7.46 7.40 7.86 8.76 9.08
Total Assets 9.99 10.66 9.75 9.68 9.59 9.17 8.81 10.10 9.93 10.23 11.36 11.82

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.64 0.09 0.58 0.06 0.34 0.12 0.58 2.16 0.47 0.40 1.03 -1.45
0.00 0.03 0.00 -0.01 -0.11 -0.01 -0.04 -0.16 -0.03 0.01 0.01 -0.23
-0.37 0.45 -0.73 -0.03 0.01 0.02 0.06 0.08 0.09 0.11 0.23 0.24
Net Cash Flow 0.27 0.57 -0.16 0.02 0.24 0.12 0.60 2.07 0.52 0.52 1.27 -1.45

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 65.51 62.53 60.83 66.65 78.31 80.79 72.22 77.03 63.36 57.69 44.65 36.89
Inventory Days 188.53 288.96 232.18 267.25 266.31 246.80 225.13 208.33 147.59 149.17 134.31 136.22
Days Payable 93.17 116.24 60.66 55.68 91.93 44.16 49.29 90.00 76.17 103.15 94.81 94.31
Cash Conversion Cycle 160.87 235.25 232.35 278.23 252.70 283.42 248.06 195.36 134.78 103.71 84.15 78.81
Working Capital Days 89.65 110.24 100.04 105.65 92.30 122.15 97.43 58.66 35.09 25.01 6.75 109.00
ROCE % 2.51% 3.20% 3.23% 3.00% 3.18% 3.40% 3.39% 4.39% 6.80% 8.08% 7.70% 6.72%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
66.01% 65.93% 66.00% 66.00% 66.00% 66.00% 66.00% 66.00% 66.00% 66.00% 66.00% 65.94%
0.12% 0.12% 0.12% 0.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
33.88% 33.95% 33.89% 33.88% 34.00% 34.00% 34.00% 34.00% 34.00% 34.00% 33.99% 34.05%
No. of Shareholders 2,6462,7942,8632,8112,8252,8732,9152,9292,9803,1163,2023,216

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports